AIM ImmunoTech Inc. Common Stock Shares Outstanding

• AIM ImmunoTech Inc. showed an increase of +368.5% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from AIM ImmunoTech Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), AIM ImmunoTech Inc.'s Common Stock Shares Outstanding has declined by 97.7%.
• Historical annual values: Fiscal year 2025: 3.07 million shares | Fiscal year 2024: 655,262 shares | Fiscal year 2023: 49.10 million shares | Fiscal year 2022: 48.08 million shares | Fiscal year 2021: 47.99 million shares | Fiscal year 2020: 42.15 million shares | Fiscal year 2019: 10.39 million shares | Fiscal year 2018: 1.11 million shares | Fiscal year 2017: 32.88 million shares | Fiscal year 2016: 24.20 million shares | Fiscal year 2015: 20.63 million shares | Fiscal year 2014: 204.00 million shares | Fiscal year 2013: 168.66 million shares | Fiscal year 2012: 166.49 million shares | Fiscal year 2011: 135.64 million shares | Fiscal year 2010: 135.24 million shares.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026